Recital 7, Regulation (EU) 2026/1215

In forcesince 11 Jun 2026

As regards infection with MTBC, Spain applied to the Commission pursuant to Article 36(1) of Regulation (EU) 2016/429 for the approval of disease-free status for the province of Huesca in the Autonomous Community of Aragon, and provided evidence demonstrating that the conditions for the recognition of disease-free status laid down in Article 36(1) of Regulation (EU) 2016/429, as supplemented by Delegated Regulation (EU) 2020/689, are fulfilled. Following the assessment of that information, the Commission considers that the condition in Article 36(1), point (d)(ii), of Regulation (EU) 2016/429, as supplemented by Delegated Regulation (EU) 2020/689, for the approval of the disease-free status of that zone in Spain, is fulfilled. Therefore, the province of Huesca in the Autonomous Community of Aragon in Spain should be listed as free from infection with MTBC in Part I of Annex II to Implementing Regulation (EU) 2021/620. Annex II to that Implementing Regulation should, therefore, be amended accordingly.